Alcresta Therapeutics is dedicated to developing and commercializing novel, enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases.
The company uses its proprietary technology platform to support a broad pipeline of products, with an initial focus on pancreatic insufficiency or fat malabsorption, which results in malabsorption common in cystic fibrosis, digestive cancers, preterm birth, and other serious diseases.
The company’s lead product, RELiZORB®, is designed to reliably and efficiently deliver the optimal nutritional and caloric benefit from existing enteral feeding formulas by improving the breakdown and absorption of fats, in particular long-chain polyunsaturated fatty acids like omega-3 (including DHA, EPA). RELiZORB is indicated for use in pediatric patients (ages 1 year and above) and adult patients to hydrolyze fats in enteral formula.
The company’s platform is supported by our extensive experience in pharmaceutical, medical device and nutritional product development. Based in Massachusetts, the company is backed by Linden Capital Partners and HealthQuest Capital.
Company Details
- Employees
- 83
- Founded
- -
- Address
- One Newton Executive Park,
- Phone
- 617-916-1207
- in****@****sta.com
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- alcresta.com
- HQ
- Newton, MA
Alcresta Therapeutics Questions
Alcresta Therapeutics's helpline number is 617-916-1207
Alcresta Therapeutics's website is alcresta.com
Alcresta Therapeutics's LinkedIn profile is https://www.linkedin.com/company/alcresta-therapeutics-inc.
Alcresta Therapeutics has
83 employees.
View email and phone details for 83
employees at Alcresta Therapeutics.
Alcresta Therapeutics's industry is
Medical Equipment Manufacturing
Alcresta Therapeutics's top competitors are
Acadia Pharmaceuticals Inc.,
Vericel® Corporation,
Allena Pharmaceuticals, Inc.,
Anagram Therapeutics, Inc.,
Sq Innovation,
Synspira Therapeutics, Inc.,
Kate Farms,
Abbvie,
Intuvie,
Insulet Corporation.
Alcresta Therapeutics's support email address is info@alcresta.com
Alcresta Therapeutics's categories are Medical Equipment Manufacturing
Alcresta Therapeutics's founding year is 2011
